Verantwortliche Person under § 20c AMG: the named role in German tissue establishments

Tissue establishments sit in a corner of German pharmaceutical law that most people in the industry never touch. Cornea banks. Bone and tendon banks. Heart valves. Amniotic membrane. Skin. Cell preparations that end up close to advanced therapies. The work is clinical in feel and pharmaceutical in regulation, and it runs on an authorisation with a named person attached.

Almost nobody writes career guidance about it, which is a shame, because the candidate market is thin and the people who fit are often sitting in university hospitals without knowing the role exists. I write this from 16 years recruiting in pharma, where named statutory responsibility was reliably the line that separated senior profiles.

What the authorisation covers

§ 20c AMG applies to processing, preserving, testing, storing or placing tissue and tissue preparations on the market where non-industrial procedures are used and the processes are well established. It sits next to § 20b AMG, which governs the removal of tissue and the laboratory testing that goes with it. Many establishments hold both, which is why the two provisions are usually discussed together and why some organisations end up with two named people rather than one.

The authority decides on the application within three months, and in exceptional cases the period can be extended by two months. That timeline matters more than it looks: an establishment that loses its responsible person is not in a position to wait comfortably, which is where the leverage of a credible candidate comes from.

The qualification, written into the provision

§ 20c names it directly. A completed university degree in human medicine, biology, biochemistry or a comparable field, and at least two years of practical work in the processing of tissue.

Two things follow. The degree list is narrower than in some other named roles, so an engineering or purely commercial background does not open this door. And the two years have to be in processing tissue specifically, which cannot be substituted by general GMP experience however strong it is. Anyone planning this move needs hands-on time in a tissue establishment on the record, and the only reliable way to get it is to go and work in one.

What the role answers for

The responsible person answers for the tissue preparations complying with the rules that apply to their processing, preservation, testing, storage and placing on the market. In daily practice that means release decisions on preparations intended for a named patient or for a bank inventory, donor documentation and traceability from donor to recipient, the validation of processing and preservation steps, the handling of deviations, and the reporting duties toward the competent authority.

The traceability requirement is the part that distinguishes this from ordinary pharmaceutical quality work. Tissue is not a batch of tablets. Each preparation carries a donor behind it and a recipient in front of it, and the documentation has to hold that chain together for a long time. People who have run that chain describe the job in a way that no course can teach.

Where these roles sit

University hospitals and their tissue banks, blood donation services, specialised cornea and bone banks, cell therapy manufacturing units attached to academic centres, and the companies that supply tissue preparations to clinics. The field overlaps with advanced therapy medicinal products, and staff move between the two, though ATMPs manufactured industrially fall under the ordinary manufacturing authorisation and the sachkundige Person rather than under § 20c.

Because the establishments are small, the named person usually carries other work as well: laboratory leadership, quality management, sometimes the clinical interface. That combination is normal here and it is worth clarifying in the interview, since the statutory responsibility does not shrink when the rest of the job grows.

The routes in

The realistic route is internal, and it starts earlier than people expect. A biologist or physician joins a tissue bank or a cell therapy unit, spends the first years on processing and documentation, takes over quality tasks, becomes the deputy, then the named person. Two years of processing work is the statutory floor, and in practice authorities and employers look for more than the minimum on a first appointment.

The second route comes from clinical laboratory work in transfusion medicine or transplantation immunology, where the donor documentation logic is already familiar. A move from classical pharmaceutical GMP into this field is possible but slower, because the processing experience has to be built from scratch and the ordinary quality background does not substitute for it.

What a CV has to evidence for this role

Be explicit about tissue types and processes: which tissues, which preservation methods, which testing, whether you worked to a § 20b or a § 20c authorisation or both. Put the two years of processing work where it can be counted, with dates. Name the traceability and documentation systems, the donor screening logic you worked under, the inspections you went through and your part in them. If you held the named appointment or the deputy position, write it with dates, because in a field this small it is the single line that gets you a call back. German applicant tracking systems match on the literal strings Gewebeeinrichtung and verantwortliche Person, so they belong in the document; the mechanics are in my guide on the ATS in pharma.

A note on salary

I will not quote a band, and here the reason is sharper than usual. Many of these establishments sit inside university hospitals and pay on public sector collective agreements, while commercial suppliers pay on industry terms. The same named responsibility can therefore carry very different compensation depending on the employer type. What is reliable: the candidate pool is small, so an establishment that needs the seat filled has limited alternatives, and that is worth knowing before you negotiate.

Frequently asked questions

What qualification does § 20c AMG require?

A completed university degree in human medicine, biology, biochemistry or a comparable field, together with at least two years of practical work in the processing of tissue. The practical experience has to be in tissue processing specifically.

How does § 20c relate to § 20b AMG?

§ 20b covers the removal of tissue and the laboratory testing connected with it, § 20c covers processing, preservation, testing, storage and placing on the market by non-industrial methods. Establishments frequently hold both authorisations, and each comes with its own named responsibility.

Is this the same as the sachkundige Person under § 14 AMG?

No. The sachkundige Person certifies and releases batches under a manufacturing authorisation. The § 20c responsible person answers for tissue preparations under the tissue authorisation, with a different qualification test and a different scope. Industrially manufactured advanced therapy products fall under the manufacturing regime rather than under § 20c.

How long does the authority take to decide?

The provision gives the authority three months to decide on the application, with an extension of up to two further months in exceptional cases.

Sources

§ 20c AMG, authorisation for tissue preparations (gesetze-im-internet.de, German)
§ 20b AMG, removal and laboratory testing of tissue (gesetze-im-internet.de, German)
Paul-Ehrlich-Institut: Gewebezubereitungen (German)

© 28 July 2026 Andreas Schulz. All rights reserved. This article is career guidance, not legal advice; the statutory text prevails.